American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| 1 |
Becton Dickinson
BDX
|
+$389M |
| 2 |
Meta Platforms (Facebook)
META
|
+$296M |
| 3 |
Salesforce
CRM
|
+$207M |
| 4 |
Howmet Aerospace
HWM
|
+$122M |
| 5 |
Reinsurance Group of America
RGA
|
+$121M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$349M |
| 2 |
Visa
V
|
+$249M |
| 3 |
IQVIA
IQV
|
+$234M |
| 4 |
T-Mobile US
TMUS
|
+$226M |
| 5 |
NXP Semiconductors
NXPI
|
+$212M |
Sector Composition
| 1 | Technology | 23.35% |
| 2 | Healthcare | 13.84% |
| 3 | Financials | 13.36% |
| 4 | Consumer Discretionary | 11.5% |
| 5 | Industrials | 10.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
VERV
2351
DELISTED
Verve Therapeutics
VERV
| $340K | ﹤0.01% |
+18,150
| New | +$340K |
|
|
AGR
2352
DELISTED
Avangrid, Inc.
AGR
| $339K | ﹤0.01% |
9,002
-66,029
| -88% | -$2.49M |
|
2353
DigitalOcean
DOCN
$3.11B
| $338K | ﹤0.01% |
8,431
+79
| +0.9% | +$3.17K |
|
2354
TETRA Technologies
TTI
$640M
| $337K | ﹤0.01% |
99,697
+19,394
| +24% | +$65.6K |
|
2355
ACM Research
ACMR
$1.8B
| $334K | ﹤0.01% |
+25,544
| New | +$334K |
|
2356
nLIGHT
LASR
$1.44B
| $329K | ﹤0.01% |
+21,340
| New | +$329K |
|
2357
Orthofix Medical
OFIX
$563M
| $328K | ﹤0.01% |
+18,165
| New | +$328K |
|
2358
Janus International
JBI
$1.4B
| $327K | ﹤0.01% |
30,678
+19,378
| +171% | +$207K |
|
|
EQRX
2359
DELISTED
EQRx, Inc. Common Stock
EQRX
| $326K | ﹤0.01% |
175,464
+63,543
| +57% | +$118K |
|
2360
Theravance Biopharma
TBPH
$687M
| $326K | ﹤0.01% |
31,482
+10,278
| +48% | +$106K |
|
2361
Graham Corp
GHM
$530M
| $325K | ﹤0.01% |
24,451
+971
| +4% | +$12.9K |
|
2362
Rush Enterprises Class B
RUSHB
$4.4B
| $324K | ﹤0.01% |
7,149
+63
| +0.9% | +$2.86K |
|
2363
Xoma
XOMA
$442M
| $322K | ﹤0.01% |
17,071
-10,966
| -39% | -$207K |
|
2364
HealthStream
HSTM
$839M
| $321K | ﹤0.01% |
+13,054
| New | +$321K |
|
2365
Vicor
VICR
$2.25B
| $320K | ﹤0.01% |
5,922
-1,968
| -25% | -$106K |
|
2366
Unity
U
$18.2B
| $320K | ﹤0.01% |
7,364
+487
| +7% | +$21.1K |
|
2367
Avis
CAR
$5.48B
| $316K | ﹤0.01% |
1,382
| – | – |
|
2368
LivaNova
LIVN
$3.09B
| $315K | ﹤0.01% |
+6,121
| New | +$315K |
|
2369
Calavo Growers
CVGW
$479M
| $315K | ﹤0.01% |
+10,842
| New | +$315K |
|
2370
Sotera Health
SHC
$4.47B
| $313K | ﹤0.01% |
16,593
+3,691
| +29% | +$69.5K |
|
2371
uniQure
QURE
$959M
| $312K | ﹤0.01% |
27,266
+9,315
| +52% | +$107K |
|
|
NXGN
2372
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $312K | ﹤0.01% |
+19,250
| New | +$312K |
|
2373
ARS Pharmaceuticals
SPRY
$1.04B
| $311K | ﹤0.01% |
46,368
+7,236
| +18% | +$48.5K |
|
2374
Columbia Financial
CLBK
$1.6B
| $310K | ﹤0.01% |
17,922
+3,863
| +27% | +$66.8K |
|
2375
Morningstar
MORN
$10.6B
| $308K | ﹤0.01% |
1,570
+7
| +0.4% | +$1.37K |
|